TechnoMark News

  Membrane chromatography mixes the chemistry of ion flow long and the processing simplicity of prepackaged capsules. The higher area of surface as well as large size of pores offer elevated binding capacities, essentially for large molecules and the elements. They can be easily integrated in the process for eliminating the impurities or for better purification of the selected molecules also known as coagulation factors, the viral vectors like, Lentivirus or AAV. The wide range of scalable formats available enable them to be utilize din countless variety of purification processes, starting from the lab to manufacturing scale. The key benefits of membrane chromatography include high binding capacity, speedy process, flexibility and scalability, easily used, cost-efficient operation, and low buffer consumption. Membrane chromatography market is estimated to be over US$ 100 Mn in 2017. It is anticipated to grow at a CAGR of 18.0% from 2019 to 2030. The continual growth of the biopharm...

  Genome editing or genome engineering is the technique that enables scientists to make modifications in an individual’s DNA. This also includes alterations in different organisms, such as bacteria, plants, and the animals. DNA editing result in changes in the physical attributes, such as color of eyes, disease risk, and more. Today, scientists are making use of various technologies to execute this process. Presently, the CRISPR technology is trending across the globe in the genome engineering field. Researchers more often make use of this improved and highly efficient technology, CRISPR to control the genome to learn the gene functionality. Nonetheless, the latest improvements in the field of gene editing technology have indicated it to be the most promising and therapeutic means also. Genome Editing/Genome Engineering Market was valued at over US$ 3.0 Bn. in 2017 and is anticipated to grow at a CAGR of 14.1% from 2019 to 2030. The growth of this market can be attributed to t...

The global veterinary CRO market was valued at $485.5 million in 2018, and is expected to reach $894.7 million by 2026, registering a CAGR of 7.9% from 2019 to 2026. Contract research organizations (CROs) are companies that aid in conducting research for a sponsor company. Moreover, veterinary CROs are companies, which are specialized in in-vivo studies that involve companion animals. Sponsor companies seek provision from veterinary CROs to support research and development programs for biopharmaceutical industries. Furthermore, different types of services are provided by veterinary CROs such as clinical trials, toxicology, and market authorization & regulatory support. These services are utilized by veterinary medicine manufacturers to test the safety and efficacy of veterinary drugs, which are used in different indications such as oncology, neurology, and infectious diseases. Major Key Players of the Veterinary CRO Market are: Charles River Laboratories, Inc., Clinvet, KLIFOVET AG...

The global medical laser market size was valued at $6,947 million in 2018, and is projected to reach $16,230 million by 2026, growing at a CAGR of 10.8% from 2019-2026. Laser stands for light amplification by stimulated emission of radiation, which has a specific wavelength creating high-intensity light. The adoption of medical lasers has increased due to its diverse medical applications including ophthalmology, dermatology, urology, cardiovascular, and others. The advantages offer by the medical lasers include reducing blood loss, decreasing postoperative discomfort, reducing the chance of wound infection, and achieving better wound healing. Major Key Players of the Medical Laser Market are: IRIDEX Corporation, Lumenis Ltd. , Ellex Medical Lasers Ltd., CryoLife, Inc. , Novartis AG, Koninklijke Philips N.V. , Biolase Inc., Boston Scientific Corporation , Bausch & Lomb Holdings, Inc. , Syneron Medical Ltd. Read More @  https://www.medgadget.com/2020/11/medical-laser-market-repor...

Gene therapy market was valued at $393.35 million in 2018, and is estimated to reach $6,205.85 million by 2026, registering a CAGR of 34.8% from 2019 to 2026. Gene therapy is a technique that involves the delivery of nucleic acid polymers into a patient’s cells as a drug to treat diseases. It fixes a genetic problem at its source. The process involves modifying the protein either to change the genetic expression or to correct a mutation. The emergence of this technology meets the rise in needs for better diagnostics and targeted therapy tools. For instance, genetic engineering can be used to modify physical appearance, metabolism, physical capabilities, and mental abilities such as memory and intelligence. In addition, it is also used for infertility treatment. Gene therapy offers a ray of hope for patients, who either have no treatment options or show no benefits with drugs currently available. The ongoing success has strongly supported upcoming researches and has carved ways for enha...

Pharmaceutical continuous manufacturing market was valued at $393 million in 2018, and is projected to reach $855 million by 2026, registering a CAGR of 10.2% from 2019 to 2026. Continuous manufacturing is advanced manufacturing approach that is performed by employing end-to-end integration of manufacturing subprocesses with a significant level of control strategies. The growth of the global pharmaceutical continuous manufacturing market is anticipated to be driven by increase in adoption of continuous manufacturing systems over existing drug manufacturing process, technological advancements in CM systems, and rise in awareness of continuous manufacturing systems in developing regions are anticipated to significantly boost the growth of the pharmaceutical continuous manufacturing market during the forecast period. Continuous pharmaceutical manufacturing system offers advantages such as reduced fluctuation in production, improved yields, lower cost of operation & equipment further a...

Pain management devices market was valued at $4,017 million in 2018, and is projected to reach $6,777 million by 2026, registering a CAGR of 6.7% from 2019 to 2026. Pain management devices are medical devices, which are used in management of different types of pain such as neuropathic pain, cancer pain, nociceptive pain, and musculoskeletal pain. Spinal cord stimulators, transcutaneous electrical nerve stimulation devices, analgesic infusion pumps, and ablation devices are different forms of pain management devices available in the market. Major Key Players of the Pain Management Devices Market are: Abbott Laboratories, B Braun Melsungen AG, Baxter International Inc., Boston Scientific Corp, DJO Global LLC, Johnson & Johnson (Codman And Shurtleff, Inc,), Kimberly Clark Corporation, Medtronic Plc, Pfizer, Inc., Stryker Corp. Read More @  https://www.medgadget.com/2020/11/pain-management-devices-market-outlook-to-2026-emerging-trends-and-will-generate-new-growth-opportunities-sta...